We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Healthpeak Properties
DOC
$15.7B
| $8.71M | 0.06% |
347,617
-23,203
| -6% | -$564K |
|
302
Titan Machinery
TITN
$458M
| $8.7M | 0.06% |
218,998
-46,866
| -18% | -$1.66M |
|
303
Ingredion
INGR
$6.48B
| $8.62M | 0.06% |
87,984
-170,188
| -66% | -$15.7M |
|
304
Ecovyst
ECVT
$1.35B
| $8.5M | 0.06% |
959,089
+280,295
| +41% | +$2.58M |
|
|
SWAV
305
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $8.42M | 0.06% |
40,942
-1,845
| -4% | -$466K |
|
|
CVSA
306
Covista Inc
CVSA
$4.3B
| $8.36M | 0.06% |
235,616
-15,397
| -6% | -$601K |
|
307
DexCom
DXCM
$28.9B
| $8.33M | 0.06% |
73,598
-8,868
| -11% | -$974K |
|
308
Eastman Chemical
EMN
$7.79B
| $8.33M | 0.06% |
102,262
+90,136
| +743% | +$7.26M |
|
309
Tenet Healthcare
THC
$22.6B
| $8.32M | 0.06% |
+170,494
| New | +$7.88M |
|
|
AD
310
Array Digital Infrastructure
AD
$3.03B
| $8.24M | 0.06% |
395,191
+301,408
| +321% | +$7.19M |
|
|
MRO
311
DELISTED
Marathon Oil Corporation
MRO
| $8.2M | 0.06% |
303,018
+251,865
| +492% | +$7.31M |
|
312
Orthofix Medical
OFIX
$496M
| $8.19M | 0.06% |
398,852
+213,179
| +115% | +$3.76M |
|
313
Intel
INTC
$435B
| $8.17M | 0.06% |
309,233
-639,326
| -67% | -$17.8M |
|
314
Titan International
TWI
$530M
| $8.16M | 0.06% |
532,702
-158,962
| -23% | -$2.27M |
|
315
Covenant Logistics
CVLG
$1.09B
| $8.11M | 0.05% |
469,478
-10,878
| -2% | -$195K |
|
|
PRA
316
DELISTED
ProAssurance
PRA
| $8.04M | 0.05% |
460,120
+112,810
| +32% | +$2.22M |
|
|
VGR
317
DELISTED
Vector Group Ltd.
VGR
| $7.93M | 0.05% |
668,233
+569,073
| +574% | +$6.01M |
|
318
WaFd
WAFD
$2.71B
| $7.89M | 0.05% |
235,095
-9,882
| -4% | -$345K |
|
319
First Solar
FSLR
$21.8B
| $7.68M | 0.05% |
51,294
-7,105
| -12% | -$1.05M |
|
320
Neurocrine Biosciences
NBIX
$18.4B
| $7.66M | 0.05% |
64,107
+50,540
| +373% | +$5.92M |
|
321
Parsons
PSN
$6.64B
| $7.65M | 0.05% |
165,447
-137,863
| -45% | -$6.35M |
|
322
Karyopharm Therapeutics
KPTI
$161M
| $7.65M | 0.05% |
149,960
+44,458
| +42% | +$3.08M |
|
323
Bankunited
BKU
$3.39B
| $7.61M | 0.05% |
223,874
+669
| +0.3% | +$23.6K |
|
|
SEE
324
DELISTED
Sealed Air
SEE
| $7.44M | 0.05% |
149,199
-10,121
| -6% | -$494K |
|
325
LendingTree
TREE
$572M
| $7.44M | 0.05% |
348,773
+131,038
| +60% | +$2.98M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.